TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/10/20 16:06 | 6/9/20 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Finizio Robert G | FL | DO | CEO | P | 66 | 1.44 | 0 | 46 | 0 | 20,402 | D | ||||||||||||||
6/8/20 16:07 | 6/5/20 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Finizio Robert G | FL | DO | CEO | P | 35 | 1.15 | 0 | 30 | 0 | 20,356 | D | ||||||||||||||
10/29/19 16:55 | 10/25/19 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Finizio Robert G | FL | DO | CEO | P | 198 | 2.75 | 0 | 72 | 0 | 20,326 | D | ||||||||||||||
8/20/19 17:12 | 8/20/19 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Finizio Robert G | FL | DO | CEO | P | 96 | 2.74 | 0 | 35 | 0 | 20,254 | D | ||||||||||||||
8/12/19 17:32 | 8/9/19 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Finizio Robert G | FL | DO | CEO | P | 155 | 2.96 | 0 | 52 | 0 | 20,219 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |